Acro Biomedical Co., Ltd. announced earnings results for the full year ended September 30, 2019. For the full year, the company announced sales was USD 1.354 million compared to USD 8.014 million a year ago. Operating loss was USD 441,553 compared to operating Income of USD 515,550 a year ago. Net loss was USD 370,747 compared to net income of USD 419,660 a year ago. Basic loss per share was USD 0.01 compared to basic earnings per share of USD 0.01 a year ago.